Steris Analyst Ratings
Piper Sandler Upgrades Steris PLC(STE.US) to Buy Rating, Raises Target Price to $260
KeyBanc Maintains Steris PLC(STE.US) With Buy Rating, Raises Target Price to $265
Wolfe Research Adjusts Price Target on STERIS to $250 From $240
Steris Price Target Maintained With a $260.00/Share by Stephens & Co.
Steris Analyst Ratings
Stephens & Co. Reiterates Overweight on Steris, Maintains $260 Price Target
JMP Securities Maintains Steris PLC(STE.US) With Buy Rating, Maintains Target Price $265
Steris Analyst Ratings
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
JMP Securities Maintains Steris PLC(STE.US) With Buy Rating, Maintains Target Price $265
Piper Sandler Reiterates Neutral on Steris, Raises Price Target to $225
KeyBanc Adjusts Price Target on STERIS to $255 From $253
J.P. Morgan Securities: Reiterated the Steris (STE.US) rating and adjusted from superior to superior market rating, with a target price of $265.00.
Steris Analyst Ratings
Needham: Reiterates that Steris (STE.US) holds the rating.
Steris Analyst Ratings
What 4 Analyst Ratings Have To Say About Steris
Stephens & Co. Reiterates Overweight on Steris, Maintains $250 Price Target
Steris Analyst Ratings